However, Muir et al reported that breast cancer in males is more frequently positive for ER than in females (male 81% vs. female 69%) and has lower HER2 overexpression (5% vs. 17%, respectively), but no significant difference in PgR (63% vs. 56%, respectively) (20). This evidence concerns the gene ERBB2 and breast cancer.